These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32308206)

  • 21. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.
    Piras V; Alves F; Gonçalo M
    Dermatol Ther; 2019 Nov; 32(6):e13098. PubMed ID: 31579975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
    Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME
    Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
    Bork K; Bernstein JA; Machnig T; Craig TJ
    J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study.
    Bork K; Hardt J; Staubach-Renz P; Witzke G
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):58-64. PubMed ID: 21601496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Icatibant in hereditary angioedema: news and challenges.
    Bouillet L
    Expert Rev Clin Immunol; 2011 May; 7(3):267-72. PubMed ID: 21595592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Several new treatment possibilities of hereditary angio-oedema].
    Aabom AL; Palarasah Y; Bygum A
    Ugeskr Laeger; 2012 Aug; 174(34):1894-8. PubMed ID: 22909569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey.
    Maurer M; Bork K; Martinez-Saguer I; Aygören-Pürsün E; Botha J; Andresen I; Magerl M
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):163-169. PubMed ID: 30176179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Icatibant as acute treatment for hereditary angioedema in adults.
    Farkas H
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
    Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
    BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of icatibant self-administration for acute hereditary angioedema.
    Boccon-Gibod I; Bouillet L
    Clin Exp Immunol; 2012 Jun; 168(3):303-7. PubMed ID: 22519593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Icatibant Outcome Survey in Patients with Hereditary Angioedema: Experience in Israel Compared with Other Countries.
    Toubi E; Kivity S; Graif Y; Reshef A; Botha J; Andresen I
    Isr Med Assoc J; 2018 Apr; 20(4):227-232. PubMed ID: 29629730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of laryngeal hereditary angioedema.
    Richman MJ; Talan DA; Lumry WR
    J Emerg Med; 2012 Jan; 42(1):44-7. PubMed ID: 21315535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hereditary angioedema. Treatment of acute attacks in Argentina].
    Malbrán A; Malbrán E; Menéndez A; Fernández Romero DS
    Medicina (B Aires); 2014; 74(3):198-200. PubMed ID: 24918666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.
    Sheffer AL; MacGinnitie AJ; Campion M; Stolz LE; Pullman WE
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):184-188.e2. PubMed ID: 23548529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective study.
    Javaud N; Gompel A; Bouillet L; Boccon-Gibod I; Cantin D; Smaiti N; Carpentier F; Boubaya M; Launay D; Adnet F; Fain O
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):499-503. PubMed ID: 25935434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema.
    Zuraw BL; Kalfus I
    Am J Med; 2012 Sep; 125(9):938.e1-7. PubMed ID: 22800873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries.
    Caballero T; Aberer W; Longhurst HJ; Maurer M; Zanichelli A; Perrin A; Bouillet L; Andresen I;
    J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1214-1222. PubMed ID: 28370444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quincke's edema: diagnosis and management of 102 patients with sudden upper airway obstruction].
    Stelter K; Lübbers CW; Andratschke M; Leunig A
    Laryngorhinootologie; 2007 Jun; 86(6):416-9. PubMed ID: 17487816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.
    Nzeako UC; Longhurst HJ
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):353-61. PubMed ID: 22410711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.